In recent years, the concept of STING pathway targeting therapeutics has generated a lot of enthusiasm within the medical science community. The growing popularity of this therapeutic technique has not only garnered the interest of several medical researchers (reflected in the increasing volume of scientific literature (1,000+ articles published since 2015) on this subject), but also industry stakeholders focused on drug development (evident in the growing number of clinical trials and the grants awarded for STING focused projects in the recent past).
To order this 310+ page report, which features 170+ figures and 200+ tables, please visit this – https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
The USD 2.8 billion (by 2030) financial opportunity within the STING pathway targeting technologies market has been analysed across the following segments:
Types of Payment
Upfront Payments
Milestone Payments
Type of STING Modulator
Agonist
Antagonist
Key Therapeutic Area(s)
Oncological Disorders
Inflammatory Disorders
Infectious Diseases
Others
Route of Administration
Intratumoral
Intravenous
Oral
Subcutaneous
Others
Type of Molecule
Non-nucleotide
Cyclic Dinucleotide
Live Biotherapeutics
Oncolytic Peptides
Synthetic Peptides
Others
Key Geographical Regions
North America
Europe
Asia-Pacific
The STING Pathway Targeting Therapeutics and Technologies, 2020-2030.” report features the following companies, which we identified to be key players in this domain:
- Aduro Biotech
- Bristol Myers Squibb
- Eisai
- GlaxoSmithKline
- ImmuneSensor Therapeutics
- Merck
- Noxopharm
- Spring Bank Pharmaceuticals
- Synlogic
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. STING Pathway Targeting Therapeutics: Current Market Landscape
5. STING Pathway Targeting Technologies: Current Market landscape
6. Company Profiles
7. Academic Grant Analysis
8. STING Related Initiatives of Big Pharmaceutical Players
9. Start-up Health Indexing
10. Publication Analysis
11. Partnerships and Collaborations
12. Funding and Investment Analysis
13. Market Sizing and Opportunity Analysis
14. Executive Insights
15. Concluding Remarks
16. Appendix 1: Tabulated Data
17. Appendix 2: List of Companies and Organizations
To purchase a copy, please visit https://www.rootsanalysis.com/reports/sting-pathway-targeting-therapeutics-and-technologies-market.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
gaurav.chaudhary@rootsanalysis.com
